Active Recombinant Human CDH8, Fc Chimera

• Cat.No.: CDH8-160H
• Product Overview: Recombinant Human CDH8 (Accession # AAA35628) was produced in Mouse myeloma cell line, NS0-derived.

Specification

• Source: Mammalian cells
• Species: Human
• Tag: Fc Chimera
• Predicted N Terminal: Ala23
• Form: Lyophilized from a 0.2 µm filtered solution in PBS.
• Bio-activity: Measured by the ability of the immobilized protein to support the adhesion of Caki-2 human clear cell carcinoma epithelial cells.When 5 x 10^4 cells/well are added to Recombinant Human Cadherin-8 Fc Chimera coated plates (5 µg/mL with 100 µL/well), approximately >30% will adhere after 30 minutes at 37 °C. Optimal dilutions should be determined by each laboratory for each application.
• Molecular Mass: Recombinant Human CDH8, Fc Chimera has a calculated MW of 93 kDa (monomer). In SDS-PAGE migrates as 116-130 kDa, reducing conditions.
• Purity: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: CDH8 cadherin 8, type 2 [ Homo sapiens ]
• Official Symbol: CDH8
• Synonyms: CDH8; cadherin 8, type 2; cadherin-8; Nbla04261
• Gene ID: 1006
• mRNA Refseq: NM_001796
• Protein Refseq: NP_001787
• MIM: 603008
• UniProt ID: P55286
• Chromosome Location: 16q22.1